BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-0.01%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.89B
AUM Growth
+$6.89B
(-8.5%)
Cap. Flow
-$366M
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
36.47%
Holding
178
New
7
Increased
49
Reduced
68
Closed
19
Top Buys
| 1 |
Medtronic
MDT
|
$49.2M |
| 2 |
Align Technology
ALGN
|
$30.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$15.6M |
| 4 |
Veeva Systems
VEEV
|
$14.1M |
| 5 |
Legend Biotech
LEGN
|
$7.35M |
Top Sells
| 1 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$159M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$27.3M |
| 3 |
DexCom
DXCM
|
$27.1M |
| 4 |
Cigna
CI
|
$26.9M |
| 5 |
Elevance Health
ELV
|
$26M |
Sector Composition
| 1 | Healthcare | 99.07% |
| 2 | Industrials | 0.84% |
| 3 | Energy | 0.03% |
| 4 | Communication Services | 0.01% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Adaptive Biotechnologies
ADPT
$1.96B
| – | – |
-2,960,131
| Closed | -$22.6M |
|
177
Acadia Healthcare
ACHC
$2.15B
| – | – |
-1,287
| Closed | -$106K |
|
178
Agilent Technologies
A
$35.5B
| – | – |
-7,978
| Closed | -$1.19M |
|